Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

personalised

- PMLiVE

Using tablet computers as pharma detail aids

How to execute digital: How pharma companies can use tablet computers such as the iPad

- PMLiVE

Making a Name for Yourself

In an overcrowded, generic-led world, it could well be time to put more emphasis on your corporate branding. Find out why...

- PMLiVE

UK diabetes spend to reach £16.9bn by 2035

In 25 years 17 per cent of NHS budget to go on the condition

- PMLiVE

Lundbeck revenues slump as competition hits Lexapro in US

New products expected to exceed revenue gap left by antidepressant

- PMLiVE

GSK gets EU nod for sarcoma drug Votrient

EMA lends further momentum to cancer drug

Merck & Co’s asthma drug Singulair faces US generic onslaught

FDA licenses versions of the brand from Teva, Sandoz, Aurobindo Pharma and others

The Research Partnership appoints Vicky McLellan to senior UK role

Healthcare market research and consultancy also promotes Pei Li Teh and Paul Reed

Richard Vellacott joins Horizon Discovery as chief financial officer

His 15 years’ industry includes time in Deloitte’s life sciences practice

Icon to set up translational medicine centre in the UK

Expands early phase research presence at new Manchester site

Teva facing bribery probe by SEC

US authorities are investigating the pharma company's activities in Latin America

NICE backs Servier’s chronic heart failure treatment Procoralan

Draft recommendation is for combination use with standard therapies

- PMLiVE

End of the line for intravenous bapineuzumab in Alzheimer’s

Negative trial results for Pfizer and Johnson & Johnson to concede defeat

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links